ClinicalTrials.gg
RecruitingNCT05794295Updated Aug 7, 2026

Sleep Architecture & Cognition in Focal Epilepsy

An interventional study of Acoustic Stimulation (AS) and SHAM Stimulation in Focal Epilepsy, sponsored by University of California, Davis. Recruiting at 1 site in United States. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by University of California, Davis · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 102 studies in Epilepsies, Partial with a site in United States — 18 open to participants now, 24 under way, 6 of them phase 3. Epilepsies, Partial · United States.

Planned enrollment
57th of 86
40 · median 100
Started
2025
with 3 others
No phase
14 of 102
6 open now
Primary completion
2026-12
later than 3 of 22 live
Registered
86th of 102
by date

Among the 102 studies in Epilepsies, Partial with a site in United States, this one is the 57th largest by planned enrollment of the 86 interventional ones that give a count, is one of 4 that started in 2025, is one of 14 with no phase, reaches primary completion later than 3 of the 22 other live ones, and was the 86th registered.

Epilepsies, Partial

243 studies on the registry are indexed under Epilepsies, Partial; 49 are open to participants now.

Browse Epilepsies, Partial studies →

Open to participants now

18 of the 102 studies in Epilepsies, Partial with a site in United States are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 37 Epilepsies, Partial studies recruiting now, 9 (24%) set no upper age limit and 24 (65%) stop at 75 or younger; 17 take children under 18; 3 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 102 studies in Epilepsies, Partial with a site in United States, or all of them as a file.
02

Study summary

Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the overnight stays, participants will have EEG leads placed and possibly a headband. They will undergo cognitive testing before they go to sleep and again in the morning. During one night of testing, sounds will be played in the room (acoustic stimulation). The sounds should not wake the participants.

Read the detailed description

This study will investigate the interconnections between sleep physiology and cognitive deficits in FE and will provide essential pilot data for an interventional trial to characterize the comprehensive effects of AS/ES on sleep and cognition in FE. The long-term goal of this project is to leverage the connections between sleep, behavior, and neural network activity to develop and implement tailored cognitive and sleep interventions for individuals with epilepsy.

AIM 1: Characterize sleep architecture patterns in Focal Epilepsy (FE) and determine the relationship to cognitive processing.

AIM 2: Determine the effect of Sleep Stimulation (Acoustic and/or electrical - AS/ES) on sleep architecture patterns and cognitive processing in FE.

Aim 1 Hypothesis: Compared to controls, FE patients will exhibit interictal epileptiform discharges (IEDs) as well as reduced sleep spindle density and slow wave power with reduced slow wave sleep spindle oscillations (SW-SSO) coupling.

Aim 1 Hypothesis: Compared to controls, reduced SW-SSO coupling during sleep in FE patients will be associated with poorer memory and attention.

Aim 2 Hypothesis: AS/ES will exhibit greater levels of SW-SSO coupling compared to Sham Stimulation.

Aim 2 Hypothesis: Compared to Sham, AS will show increased connectivity on EEG, and improved memory and attention.

03

Conditions studied

  • Focal Epilepsy

Keywords

  • Epilepsy
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 - 40 years of age
  • Focal Epilepsy
  • Capacity to fully cooperate and follow directions
  • no other significant neurological disorders which could affect cognition

Exclusion criteria

Exclusion Criteria:

  • Current use of any medications that can significantly affect cognition
  • No severe sleep apnea
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Acoustic Stimulation (AS)

    Participants in this arm will be exposed to acoustic stimulation while they sleep during a night of monitoring.

    Other: Acoustic Stimulation (AS)

  • Sham comparator
    SHAM Stimulation

    Participants in this arm will not be exposed to any stimulation while they have their sleep monitored for one night.

    Other: SHAM Stimulation

Interventions

  • OtherAcoustic Stimulation (AS)

    Acoustic Stimulation will be administered while participants have their sleep monitored.

  • OtherSHAM Stimulation

    No stimulation will be administered while participants have their sleep monitored.

06

What researchers measure

Primary outcomes

  1. Stanford Sleepiness Scale

    Alertness Test; charts how alert a participant feels for up to 18 hours of the day for 7 days; scale is from 1-7 with higher scores meaning more sleepiness; abnormal is 4 and above

    Time frame: participant completes over one week post EMU stay

  2. Pittsburgh Sleep Quality Index (PSQI)

    used to measure quality and patterns of sleep in adults

    Time frame: screening

  3. Epworth Sleepiness Scale

    subjective measure of a patient's sleepiness; scores are from 0-24 with higher scores meaning more sleepiness; abnormal is 10 and above

    Time frame: screening

  4. Karolinska Sleepiness Scale / Sleep Diary

    Self-administered indication of sleepiness; scores are from 1-9 with higher scores meaning more sleepiness; abnormal is 7 and above

    Time frame: screening

  5. Vigor Affect Visual Analog Scale

    self-administered assessment of mood; scores are from 0-10; depending on the question, higher score can mean more sleepiness or less sleepiness

    Time frame: screening

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2023
First posted
Apr 3, 2023
StartActual
Jan 24, 2025
Primary completionEst.
Dec 1, 2026
CompletionEst.
Jun 2028
Last update
Aug 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05794295
Responsible party
Sponsor
First posted
Apr 3, 2023
Start date
Jan 24, 2025
Primary completion
Dec 1, 2026 (estimated)
Completion
Jun 2028 (estimated)
Last update
Aug 7, 2026

Study contacts

Temitayo Oyegbile-Chidi, MD
Contact
oyegbilechidi@health.ucdavis.edu
916-318-3111

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion